Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
RAPT Therapeutics, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2029 | $18.15M | $18.15M - $18.15M | -$3.63M | -$6.468 | 3 |
| Dec 2028 | $83.70M | $83.70M - $83.70M | -$16.74M | -$4.803 | 4 |
| Dec 2027 | $805.4K | $805.4K - $805.4K | -$161.1K | -$3.707 | 4 |
| Dec 2026 | $10.19M | $10.19M - $10.19M | -$2.04M | -$3.172 | 4 |
| Dec 2025 | $768.4K | $768.4K - $768.4K | -$153.7K | -$2.402 | 4 |
| Dec 2024 | $0.00 | $0.00 - $0.00 | $0.00 | -$14.706 | 0 |
| Dec 2022 | $1.69M | $1.69M - $1.69M | -$337.8K | -$20.476 | 1 |
| Dec 2021 | $3.89M | $3.89M - $3.89M | -$777.1K | -$20.592 | 1 |
| Dec 2020 | $4.59M | $4.59M - $4.59M | -$918.1K | -$17.525 | 1 |